In the continuation of our research, we focused on RASGEF1A due to its distinct association with the RAS pathway, a crucial signaling cascade implicated in cancer development and progression, with dysregulation of the Ras signaling pathway reported to lead to uncontrolled cell proliferation and resistance to apoptosis [42]. This evidence concerns the gene RASGEF1A and cancer.